Investigation of Genetic and Molecular Mechanisms of Second Malignant Neoplasms in a Mouse Model |
University of California San Francisco / Jean Nakamura |
Young Investigator Grants |
2011 |
California |
The Role of Prmt1 in Osteosarcoma Initiation and Metastasis |
Dana-Farber Cancer Institute / Hao-Ru Hsu, PhD |
Young Investigator Grants |
2013 |
Massachusetts |
A Developmental Model to Characterize the Epigenetic Origins of the Retinoblastoma Tumor Initiating Cell |
The Johns Hopkins University School of Medicine / Jeffrey Huo, MD, PhD |
Young Investigator Grants |
2014 |
Maryland |
Identification and Characterization of an Epigenetic Program that Maintains the Self-Renewal of MLL Myeloid Leukemia Stem Cells |
Stanford University / Hon-Kit Wong |
Young Investigator Grants |
2010 |
California |
A Translational Approach to Identify Drugs with Specific Activity Against EZH2 Mutant High Risk T-ALLs and ETP ALLs that Overexpress the JDP2 bZIP Transcription Factor |
Dana-Farber Cancer Institute / Shuning He, PhD |
Young Investigator Grants |
2015 |
Massachusetts |
Novel Synergistic Targets for Combination Therapy in Philadelphia Chromosome-like Acute Lymphoblastic Leukemia |
Children’s Hospital of Philadelphia / Yang Ding, MD |
Young Investigator Grants |
2020 |
Pennsylvania |
Modeling H3 G34R and BCOR-Altered Glioma Pathogenesis Using Neural Stem Cells |
The Johns Hopkins University School of Medicine / Satoshi Nakata, MD/PhD |
Young Investigator Grants |
2019 |
Maryland |
Mechanisms of regulation of the PI#K/AKT pathway downstream of NOTCH1 in T-ALL.
|
Columbia University / Teresa Palomero, PhD |
Young Investigator Grants |
2007 |
New York |
PRL3 as a Novel Therapeutic Target for Relapsed T-cell Acute Lymphoblastic Leukemia |
Massachusetts General Hospital / Jessica Blackburn, PhD |
Young Investigator Grants |
2013 |
Massachusetts |
APOBEC3 in Pediatric Leukemia: a Biomarker for Sensitivity to PARP Inhibition? |
Children’s Hospital of Philadelphia / Abby Green, MD |
Young Investigator Grants |
2014 |
Pennsylvania |